The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution

被引:15
作者
Kim, Seung Tae [1 ]
Ha, Sang Yun [2 ]
Lee, Jeeyun [1 ]
Hong, Sung No [3 ]
Chang, Dong Kyung [3 ]
Kim, Young Ho [3 ]
Park, Yoon Ah [4 ]
Huh, Jung Wook [4 ]
Cho, Yong Beom [4 ]
Yun, Seong Hyeon [4 ]
Lee, Woo Yong [4 ]
Kim, Hee Cheol [4 ]
Park, Young Suk [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Gastroenterol,Dept Med, Seoul, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea
关键词
PROGNOSTIC-FACTORS; DIAGNOSIS;
D O I
10.1097/MD.0000000000003534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The clinicopathologic features of hindgut neuroendocrine tumor (NET) as well as the treatment outcomes are not well known. There are currently no published data on treatment outcomes for patients with metastatic hindgut NET. The aim of this study was to conduct a comprehensive analysis of clinicopathologic features, treatments and survival in hindgut NET patients. Among patients who were pathologically diagnosed with hindgut NET at Samsung Medical Center between March 2001 and February 2015, 607 were analyzed in this study. Hindgut NETs were defined as NETs that originated from the transverse and distal colon, rectum, and anus. Primary sites included 81 colon (13.3%) and 526 rectum (86.7%). According to the WHO classification, 578 patients (95.2%) had grade 1 NETs, 17 (2.8%) grade 2 NETs, and 12 (2.0%) had neuroendocrine carcinoma (NEC). Forty-two patients (6.9%) had extensive disease, while the majority (93.1%, 565 patients) only exhibited localized disease. The 5- and 10-year survival rates of 565 localized NET patients were 98.1% and 95.3%, respectively. The median OS in 42 patients with extensive disease was 24.8 months (95% CI, 10.7-38.8). Among 565 patients with localized disease, the majority (484 patients, 85.7%) were treated with endoscopic procedure by gastroenterologists. For 42 patients with extensive disease, 17 patients were managed by supportive care, 3 by concurrent chemoradiotherapy (CCRT), and 22 by systemic therapy. Among these 22 patients, 12 patients received only first-line therapy, 8 had second-line, and only 2 patients had third-line therapy. As first-line chemotherapy, the most commonly used regimens were etoposide plus cisplatin (N=7) and long acting octreotide (N=7). During treatment courses, the most commonly used regimen was long-acting octreotide. The median OS in 22 metastatic NET patients receiving systemic therapy was 19.3 months (95% CI, 3.2-35.3). Multivariate analysis in all 607 hindgut NETs patients suggested that the extent and the primary site of disease were significant independent prognostic factors for long term survival. This analysis provides useful information about the clinicopathologic features, treatments and survival outcomes for hindgut NET patients.
引用
收藏
页数:5
相关论文
共 20 条
[1]   The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs) Well-Differentiated NETs of the Distal Colon and Rectum [J].
Anthony, Lowell B. ;
Strosberg, Jonathan R. ;
Klimstra, David S. ;
Maples, William J. ;
O'Dorisio, Thomas M. ;
Warner, Richard R. P. ;
Wiseman, Gregory A. ;
Benson, Al B., III ;
Pommier, Rodney F. .
PANCREAS, 2010, 39 (06) :767-774
[2]   Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study [J].
Cho, Mee-Yon ;
Kim, Joon Mee ;
Sohn, Jin Hee ;
Kim, Mi-Jung ;
Kim, Kyoung-Mee ;
Kim, Woo Ho ;
Kim, Hyunki ;
Kook, Myeong-Cherl ;
Park, Do Youn ;
Lee, Jae Hyuk ;
Chang, HeeKyung ;
Jung, Eun Sun ;
Kim, Hee Kyung ;
Jin, So-Young ;
Choi, Joon Hyuk ;
Gu, Mi Jin ;
Kim, Sujin ;
Kang, Mi Seon ;
Cho, Chang Ho ;
Park, Moon-Il ;
Kang, Yun Kyung ;
Kim, Youn Wha ;
Yoon, Sun Och ;
Bae, Han Ik ;
Joo, Mee ;
Moon, Woo Sung ;
Kang, Dae Young ;
Chang, Sei Jin .
CANCER RESEARCH AND TREATMENT, 2012, 44 (03) :157-165
[3]  
Colonoscopy Study Group of Korean Society of Coloproctology, 2011, J Korean Soc Coloproctol, V27, P17, DOI 10.3393/jksc.2011.27.1.17
[4]   Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer [J].
Hanna, N ;
Bunn, PA ;
Langer, C ;
Einhorn, L ;
Guthrie, T ;
Beck, T ;
Ansar, R ;
Ellis, P ;
Byrne, M ;
Morrison, M ;
Hariharan, S ;
Wang, B ;
Sandler, A .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :2038-2043
[5]   Changes in colorectal cancer during a 20-year period: An extended report from the multi-institutional registry of large bowel cancer, Japan [J].
Kotake, K ;
Honjo, S ;
Sugihara, K ;
Kato, T ;
Kodaira, S ;
Takahashi, T ;
Yasutomi, M ;
Muto, T ;
Koyama, Y .
DISEASES OF THE COLON & RECTUM, 2003, 46 (10) :S32-S43
[6]   The role of chemotherapy and/or octreotide in patients with metastatic gastroenteropancreatic and hepatobiliary neuroendocrine carcinoma [J].
Lee, Suk-young ;
Choi, Yoon Ji ;
Chang, Won Jin ;
Shin, Sang Won ;
Kim, Yeul Hong ;
Kim, Seung Tae .
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 5 (06) :457-462
[7]   Gastroenteropancreatic neuroendocrine tumors: Incidence and treatment outcome in a single institution in Korea [J].
Lim, Taekyu ;
Lee, Jeeyun ;
Kim, Jae J. ;
Lee, Jong Kyun ;
Lee, Kyu Taek ;
Kim, Young Ho ;
Kim, Kwang-Won ;
Kim, Sung ;
Sohn, Tae Sung ;
Choi, Dong Wook ;
Choi, Seong Ho ;
Chun, Ho-Kyung ;
Lee, Woo Young ;
Kim, Kyoung-Mee ;
Jang, Kee-Taek ;
Park, Young Suk .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (03) :293-299
[8]   Updated population-based review of carcinoid tumors [J].
Maggard, MA ;
O'Connell, JB ;
Ko, CY .
ANNALS OF SURGERY, 2004, 240 (01) :117-122
[9]   Viability of endoscopic and excisional treatment of early rectal carcinoids [J].
Merg, Anders ;
Wirtzfeld, Debrah ;
Wang, Jiping ;
Cheney, Richard ;
Dunn, Kelli Bullard ;
Rajput, Ashwani .
JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (07) :893-897
[10]   Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles [J].
Minoo, P. ;
Zlobec, I. ;
Peterson, M. ;
Terracciano, L. ;
Lugli, A. .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (03) :707-718